{
    "2021-07-13": [
        [
            {
                "time": "",
                "original_text": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中期策略",
                        "需求长期景气",
                        "创新",
                        "医疗服务",
                        "消费主线"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“茅指数”躺赢策略失效，“宁组合”市场表现抢眼",
                "features": {
                    "keywords": [
                        "茅指数",
                        "躺赢策略",
                        "失效",
                        "宁组合",
                        "市场表现抢眼"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}